At Ambry Genetics, we want to empower you to navigate your healthcare with confidence. Learn what you need to here.
Patients & Genetic Testing
For over 25 years our high-quality, accessible genetic testing solutions have shaped important care decisions.
Take Action with Ambry
At Ambry, we want to make industry-leading genetic testing accessible and affordable.
Billing & Insurance
We never lose sight of the fact that there is a human life attached to every sample and every result.
Ordering & Kits
Our Tests
At Ambry, we offer materials to support healthcare providers throughout the genetic testing process.
Additional Resources
Solutions
Ambry’s Patient for Life™ Program proactively reanalyzes patients’ results as new gene-disease associations emerge, transforming a static report into lifelong diagnostic insights.
Our CARE (Comprehensive Assessment, Risk, and Education) platform integrates a suite of digital health tools to help healthcare providers identify high-risk patients for certain health conditions and/or who qualify for genetic testing.
When it comes to finding potentially life-changing answers for your patients, you deserve a lab partner with a name built on trust.
+RNAinsight® provides comprehensive gene coverage for RNA analysis to help classify DNA variants associated with cancers of breast, ovarian, prostate, colon, pancreatic, uterine, and more.
Behind every effective drug therapy is a patient who once had only hope and now has an answer. Life-changing answers. And finding answers starts with the right diagnostic partner.
Ambry is committed to the advancement of genetics. We participated in the largest study of its kind (20,000 patients) to validate the effectiveness of confirmation testing.
Collaborating for scientific advancement. Interested in collaborating with us?
At Ambry Genetics, we are driven to giving healthcare providers the most advanced genetic testing information available so they can determine the best treatment options for their patients.
Company
We are driven to give healthcare providers the most advanced testing information available so you can determine the best treatment options for your patients.
Explore upcoming conferences and events where Ambry Genetics shares research, engages with clinicians and partners, and contributes to advancing genetic insights worldwide.
Browse through our collection of press releases.
Access official Ambry Genetics media resources including logos, executive headshots, and press-ready materials to support accurate coverage of our mission and innovations.
For clinicians, patients, and the curious — insights on genomics, hereditary conditions, and the stories that remind us why this work matters.
A career at Ambry offers the chance to be part of a passionate, intelligent team that is innovating the future of genomics.
Back to Press Releases
Ehlers-Danlos, vascular type (EDS IV)
